Getting real about herpes bi2731972 One four has it. And shouldn't be a relationship death sentence. by Melysa Martinez A few weeks ago, a website called Str8Media caused quite the stir on a local and national level after published statistics by the Center for Disease Control and Prevention listed the top 15 cities the worst herpes rates the country. So city, you ask, was sitting pretty at No. 1 ..

Vical Reports 2011 Financial Results and Progress Key Development Programs bi2731972 SAN DIEGO -- Vical Incorporated today reported financial results for the year ended December 31, 2011. Vical had cash and investments of approximately $56 million at year-end 2011. In addition, the company ..

Experts: Equine herpes on rise, but not an epidemic bi2731972 Horses are exercised at the Eldorado Polo Club during a state-imposed quarantine of the area after a horse at Empire Polo Club tested positive for the equine herpes virus and had to be euthanized

Recent Asahi Kasei Pharma News bi2731972 Tokyo, Feb 7, 2012 (JCN) - Asahi Kasei Pharma Corp. recently filed an application for approval of the antiviral agent Famvir, was developed Japan jointly Maruho Co. Ltd, for the additional indication of herpes simplex

Benefits of Male Circumcision [Letters] bi2731972 To the Editor: Drs Tobian and Gray 1 highlight the medical benefits of male circumcision, especially protection against infection the sexually transmitted viral pathogens HIV, herpes simplex virus, and human papillomavirus

Antiviral Therapeutics - Technologies, Markets and Companies bi2731972 NEW YORK, Feb. 1, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report available catalogue: Antiviral Therapeutics - Technologies, markets and companies http://www.reportlinker.com/p0203535/Antiviral-Therapeutics---Technologies-markets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=TherapyThis ..

Medivir: Medivir?s Partner GSK Initiates OTC Launch of Xerclear® Europe un bi2731972 Regulatory News:..

Medivir's Partner GSK Initiates OTC Launch of Xerclear® Europe Under Trade bi2731972 HUDDINGE, Sweden, February 8, 2012 /PRNewswire/ --Medivir AB (OMX: MVIR), the research-based specialty pharmaceutical company focused on infectious diseases, announces that unique cold sore product ..

Press Release bi2731972 Astra Biotech GmbH preparing to launch a range of test kits for the diagnosis and monitoring of infectious diseases the potential for significant pathogenesis

Internet Remote Access - Home